NMDP operates a blood stem cell registry and transplant network for patients with blood cancers and disorders. The tech stack reveals an organization mid-modernization: Oracle EBS underpins operations while cloud (AWS, OCI) and vector databases (Pinecone, Qdrant, Weaviate, pgvector, Milvus) signal active AI/ML integration. Active projects around cloud-native pipelines, LLM orchestration, and platform modernization paired with security-focused AI reviews indicate engineering is building production ML capabilities—a shift from registry-as-database toward AI-assisted matching and patient outcomes.
NMDP, founded in 1987 and headquartered in Minneapolis, is a global nonprofit that maintains the world's most diverse blood stem cell donor registry and operates a network of transplant centers, physicians, and patient advocates. The organization facilitates connections between donors, researchers, and patients to accelerate cell therapy development for blood cancers (leukemia, lymphoma), hemoglobinopathies (sickle cell disease), and related blood disorders. With 1,001–5,000 employees across the United States, NMDP combines donor recruitment, bioinformatics, medical research coordination, and transplant logistics at operational scale.
NMDP uses Oracle EBS, Oracle Fusion, and Oracle HCM Cloud for enterprise operations; AWS and OCI for cloud infrastructure; Salesforce for donor and patient engagement; Snowflake for data warehousing; and vector databases (Pinecone, Qdrant, Weaviate, pgvector, Milvus) for emerging AI/ML work.
NMDP is building cloud-native AI/ML pipelines, integrating multiple large language models (OpenAI, Claude, Gemini, LLaMA via Hugging Face), and developing reusable ML frameworks—with active security reviews to move solutions to production.
Other companies in the same industry, closest in size